Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001801170-24-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-18 | 2024-03-14 | CLOV | Loengard Anna U | Dir | P - Purchase | $0.73 | +13.6K | 15.1K | +908% | +$9,946 |
| 2024-03-18 | 2024-03-14 | CLOV | Loengard Anna U | Dir | P - Purchase | $0.73 | +137.0K | 538.8K | +34% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-14 | P | A | 13,625 | $0.73 | 15,125 | I | — | — | |
| 2 | Common | Class A Common Stock | 2024-03-14 | P | A | 137,000 | $0.73 | 538,841 | D By Daughter in a Custodial Account | — | — | (F1) The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |